HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases

Histone deacetylase (HDAC) inhibitors are powerful epigenetic regulators that have enormous therapeutic potential and have pleiotropic effects at the cellular and systemic levels. To date, HDAC inhibitors are used clinically for a wide variety of disorders ranging from hematopoietic malignancies to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hull, Elizabeth E., Montgomery, McKale R., Leyva, Kathryn J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983322/
https://www.ncbi.nlm.nih.gov/pubmed/27556043
http://dx.doi.org/10.1155/2016/8797206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983322/
https://www.ncbi.nlm.nih.gov/pubmed/27556043
http://dx.doi.org/10.1155/2016/8797206

Ejemplares similares